The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma

MLA

Berry, Teeara, et al. “The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma.” Cancer Cell, vol. 22, no. 1, July 2012, pp. 117–30. EBSCOhost, https://doi.org/10.1016/j.ccr.2012.06.001.

APA

Berry, T., Luther, W., Bhatnagar, N., Jamin, Y., Poon, E., Sanda, T., Pei, D., Sharma, B., Vetharoy, W. R., Hallsworth, A., Ahmad, Z., Barker, K., Moreau, L., Webber, H., Wang, W., Liu, Q., Perez-Atayde, A., Rodig, S., Cheung, N.-K., & Raynaud, F. (2012). The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma. Cancer Cell, 22(1), 117–130. https://doi.org/10.1016/j.ccr.2012.06.001

Chicago

Berry, Teeara, William Luther, Namrata Bhatnagar, Yann Jamin, Evon Poon, Takaomi Sanda, Desheng Pei, et al. 2012. “The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma.” Cancer Cell 22 (1): 117–30. doi:10.1016/j.ccr.2012.06.001.